Study of QMF149 (150/80 µg) Compared With MF Twisthaler® (200 µg) in Patients With Asthma

Mild Asthma Clinical Trial

Official title:
A Multi-center, Randomized, 12-week Treatment, Doubleblind Study to Assess the Efficacy and Safety of QMF149 (150/80 Microgram) Compared With MF Twisthaler® (200 Microgram) in Adult and Adolescent Patients With Asthma

Status Completed

Clinical Trial Summary

The purpose of the trial was to evaluate efficacy and safety of QMF149 150/80 microgram o.d. delivered via Concept1 compared to MF 200 microgram o.d., delivered via Twisthaler® in terms of lung function and symptom control in poorly (ie inadequately) controlled asthma patients. This study was to assess contribution of LABA as an add-on therapy to low dose ICS monotherapy.

Clinical Trial Description

The primary objective of this study was to demonstrate the superiority of QMF149 150/80 microgram o.d. (in the evening) delivered via Concept1 compared with MF 200 microgram o.d. (in the evening) delivered via Twisthaler® in terms of trough FEV1 after 12 weeks of treatment in adults and adolescents. The key secondary objective of this study was to demonstrate the superiority of QMF149 150/80 microgram to MF 200 microgram o.d. in terms of ACQ-7 after 12 weeks of treatment. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02892344
Study type	Interventional
Source	Novartis
Contact
Status	Completed
Phase	Phase 3
Start date	January 16, 2017
Completion date	November 30, 2018

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT00380354` - Study To Evaluate GSK256066 In Subjects With Mild Bronchial Asthma	Phase 2
Completed	`NCT00453778` - A Study To Investigate The Effect Of Inhaled Fluticasone Propionate On The Bronchial Responsiveness To Leukotriene D4 In Asthmatics Patients	Phase 4
Recruiting	`NCT04796844` - MANI Real-life Perspective Observatory
Completed	`NCT00466596` - Effect of House Dust Mite Allergen Challenge in Persons Using 1200 mg Gamma Tocopherol Supplements	Phase 1
Completed	`NCT00287365` - Genetic Susceptibility to Ozone in Mild Asthmatic Volunteers	N/A
Completed	`NCT00448851` - Study of Dust Mite Inhalation in Humans	Phase 1
Completed	`NCT03838731` - Study in Cat-Allergic Patients With Asthma to Evaluate the Efficacy of a Single Dose of REGN1908-1909 to Reduce Bronchoconstriction Upon Cat Allergen Challenge	Phase 2
Completed	`NCT03421730` - A Study of the Pharmacokinetics, Safety and Tolerability of Single Doses of VR647 Inhalation Suspension Administered Using the VR647 Inhalation System in Children With Wheezing, Reactive Airway Disease or Mild Asthma	Phase 1
Recruiting	`NCT04912596` - Pharmacodynamic Equivalence of the Test and Reference Metered Dose Inhalers (MDIs) Containing Albuterol Sulfate in Adult Patients With Stable Mild Asthma	N/A